The $1.3 Trillion Global Pharma Industry's #1 New Disruptor? Pharma supply chain companies are absolutely killing it. This one, in particular, recently joined the Nasdaq. With 160+ clients and vendors, they have a global network that is mind-blowing. Killer revenue growth of 40% gross profit growth of nearly 120% paints a picture of a Pharma company on the rise. [AD] Strong subsidiaries and an industry-leading management team, could see them thrive... |